CABA
Cabaletta Bio Inc
NASDAQ: CABA · HEALTHCARE · BIOTECHNOLOGY
$2.78
-2.80% today
Updated 2026-04-29
Market cap
$328.40M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$1 – $4
Volume
2.2M
Cabaletta Bio Inc (CABA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-127.00%
ROA
-61.50%
Debt/equity
0.18x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-250000.00 | — | — | — |
| 2018 | $0.00 | $-12.20M | — | — | — |
| 2019 | $0.00 | $-15.10M | — | — | — |
| 2020 | $0.00 | $-32.49M | — | — | — |
| 2021 | $0.00 | $-45.53M | — | — | — |
| 2022 | $0.00 | $-51.81M | — | — | — |
| 2023 | $0.00 | $-67.67M | — | — | — |
| 2024 | $0.00 | $-115.86M | — | — | — |
| 2025 | $0.00 | $-167.86M | — | — | — |